Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APT-1011 in Adolescent Eosinophilic Esophagitis
NCT05083312Phase 3Completed
- Sponsor
- Ellodi Pharmaceuticals
- Start
- Sep 2021
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of fluticasone propionate in eosinophilic esophagitis (EoE), sponsored by Ellodi Pharmaceuticals. Started Sep 2021; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT05083312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05083312.